ABSTRACT: We investigated if time between injury and surgery affects cancellous bone properties in patients suffering tibial plateau fractures (TPF), in terms of structural integrity and gene expression controlling bone loss. A cohort of 29 TPF, operated 1-17 days postinjury, had biopsies from the fracture and an equivalent contralateral limb site, at surgery. Samples were assessed using micro-computed tomography and real-time RT-PCR analysis for the expression of genes known to be involved in bone remodeling and fracture healing. Significant decreases in the injured vs control side were observed for bone volume fraction (BV/TV, À13.5 AE 6.0%, p ¼ 0.011), trabecular number (Tb.N, À10.5 AE 5.9%, p ¼ 0.041) and trabecular thickness (Tb.Th, À4.6 AE 2.5%, p ¼ 0.033). Changes in these parameters were more evident in patients operated 5-17 days post-injury, compared to those operated in the first 4 days post-injury. A significant negative association was found between Tb.Th (r ¼ À0.54, p < 0.01) and BV/TV (r ¼ À0.39, p < 0.05) in relation to time post-injury in the injured limb. Both BV/TV and Tb.Th were negatively associated with expression of key molecular markers of bone resorption, CTSK, ACP5, and the ratio of RANKL:OPG mRNA. These structure/gene expression relationships did not exist in the contralateral tibial plateau of these patients. This study demonstrated that there is a significant early time-dependent bone loss in the proximal tibia after TPF. This bone loss was significantly associated with altered expression of genes typically involved in the process of osteoclastic bone resorption but possibly also bone resorption by osteocytes. The mechanism of early bone loss in such fractures should be a subject of further investigation. ß
Tibial plateau fractures (TPF), articular fractures of the knee, cause grave short-and medium-term disability, and come at a very high cost to the healthcare system and society. At a minimum, patients require surgery, often with extended periods of hospitalization and non-weight-bearing. In the medium-to long-term, many patients develop post-traumatic arthritis and are five times more likely than the general population to require knee replacement surgery. 1 With current treatment protocols, patient outcomes following repair of articular tibial plateau fractures are highly unsatisfactory: Perfect realignment of the joint ("fracture reduction") is not achieved for 30% of otherwise healthy patients. 2 Articular fracture reduction and maintenance of reduction throughout fracture healing are considered of paramount importance for optimal outcomes after TPF. 3 Experience suggests that reduction of articular fractures becomes increasingly difficult as time since injury increases. This has been proven for acetabular fractures. 4 Furthermore, it was shown that if surgery is performed more than 2 weeks after injury for complex acetabular fractures, anatomic reduction cannot be achieved. 5 The difficulty in reducing articular fractures as time since injury passes is undoubtedly multifactorial and includes the increased difficulty in fracture mobilization as callus forms and soft tissue swells. Other mechanisms could include the deformation and crushing of cancellous bone fracture fragments as they move against each other, before internal fixation, and as the fragments are manipulated at the time of surgery. These last factors could be compounded if there was a significant post-traumatic bone loss at the fracture site before open reduction and internal fixation (ORIF) is performed.
Previous studies have shown post-traumatic bone loss, distant from the fracture, in the injured bone to be higher than 20% 6, 7 and detectable as early as 6 weeks after injury. 8, 9 In humans, post-traumatic bone loss has been shown to preponderantly affect the cancellous bone surrounding a diaphyseal fracture. 7, 10 These studies, however, have used peripheral quantitative computed tomography (pQCT), dual energy X-ray absorptiometry (DEXA) and quantitative ultrasound 7 to measure bone loss. Although pQCT and DEXA show similar measurements when investigating the same patient, 7 these methods are both affected by any metalwork used for internal fixation 7 and neither is clinically applicable before metaphyseal fracture reduction, as the results would be affected by fracture fragment displacement, compression, and overlap.
It is currently unknown whether post-injury bone loss occurs in the very early stages after injury prior to surgical treatment, but prior data has suggested bone could be lost during the first few weeks after fracture at a rate of 0.2 g/cm 3 /week. 10 Post-injury bone loss was associated with loss in mechanical competence, linked to the failure of fracture reduction after internal fixation and is thought to play a significant role in loosening of implants used to perform osteosynthesis. 11, 12 Therefore, if significant post-traumatic bone loss was to occur at a metaphyseal fracture site before surgical treatment, together with the potential residual subchondral voids left by the reduction of depressed or impacted articular fragments, it could challenge the fixation and stability achieved for osteochondral fragments.
Currently, the mechanism of bone loss in the fractured bone after injury is largely unknown. A better understanding of the mechanisms involved could lead to more effective intervention.
Augat and Claes 11 have demonstrated increased cortical remodeling due to elevated numbers of active osteons as a cause of post-traumatic osteopenia. Serum bone markers indicate an increased osteoclastic activity as early as 1 week after a fracture 13 and osteoclastic activity was identified at fracture surfaces where osteoclasts resorb necrotic bone.
14 Bone expression of receptor activator NF-kB ligand (RANKL), the RANKL inhibitor, osteoprotegerin (OPG), and their dynamic interactions are critical to the process of bone resorption and osteoclastogenesis. 15 These have previously been shown to relate to human trabecular bone microarchitecture 16 and are therefore likely candidates. Osteoclast gene products involved in the resorption process, including the bone matrix degrading enzyme cathepsin K (CTSK) and tartrate resistant acid phosphatase (TRAP/ACP5) could also be predicted to provide mechanistic insight into this process. Interestingly, these markers are also expressed by osteocytes, which we and others have shown are capable of removing bone by the process of osteocytic osteolysis. [17] [18] [19] Consistent with this, we showed recently that osteocytes can potentially contribute to the pool of b-CTX, a major clinical marker of bone resorption. 20 In this study, we hypothesized that there is posttraumatic bone loss in TPF before ORIF has taken place, we sought to quantify this bone loss by using micro-computed tomography (micro-CT) and investigate its potential mechanism by using gene expression analysis.
MATERIALS AND METHODS

Patients
This study was approved by the human research ethics committee of the Royal Adelaide Hospital (Approval No. HREC/16/RAH/418). Patients enrolled in the study provided written informed consent. All patients who had a unilateral TPF treated surgically since February 2014 were asked to participate. Consenting patients had bone biopsies taken from the injured and uninjured tibial plateaus taken at the time of ORIF. In addition clinical data were recorded from the patient case notes. Patient age, sex, body mass index (BMI), smoking status, pre-operative haemoglobin, and diabetes were assessed in addition to fracture type and time from injury to surgery. The mechanism of injury was classified as either low energy, such as that sustained from a simple fall, with high energy injuries having been sustained in motor vehicle accidents or similar. The fractures were classified using both the AO Trauma 21 and Schatzker 22 classification systems.
Bone Biopsy Procedure
At surgery both legs were cleaned, prepared with alcoholic chlorhexidine (ChloraPrep
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; CareFusion, Inc., Leawood, KS), and after drying draped sterile. Biopsies were obtained from both the injured and contralateral limbs. The biopsy from the injured side was taken after fracture reduction, before completion of the internal fixation. The biopsy was taken by one of two surgeons (LBS, PJS) from the largest fracture fragment before drilling from the site where screws were to be placed at a minimum distance of 6 mm from the articular surface, to minimize regional differences in the bone microarchitecture of the proximal tibia. 23 The biopsy from the uninjured side was then taken percutaneously under image intensifier (II) control from the corresponding part of the proximal tibia to match the biopsy site taken from the injured limb as closely as possible (Fig. 1) .
All biopsies were taken using an 8-gauge T-Lok TM Bone Marrow Biopsy Needle (ARGON Medical Devices Inc. Athens, TX). Cylindrical biopsies with a diameter of 2.7 mm and a length 20-30 mm were harvested. As the biopsies were removed from the needle, some were fragmented, due to either delivery from the biopsy needle or fracture fragment comminution. Of the two biopsies taken from each site, one was placed in 70% ethanol and examined by micro-CT to determine standard measures of trabecular bone microarchitecture, 24 while the other was placed into sterile saline and processed for gene expression analysis (see section Real-Time Reverse Transcription PCR) for genes associated with bone remodeling. Only biopsies that did not fragment, or only broke in two pieces (and were therefore re-constructible), were examined by micro-CT. All personnel performing micro-CT and real-time RT-PCR analyses were blinded to the site of harvesting, that is, the injured or uninjured side, until all results were reviewed for comparison.
Micro-CT Analysis
To quantify the trabecular bone microarchitecture, biopsies were scanned by micro-CT (Skyscan, Model 1076, Bruker, Kontich, Belgium). 25 Biopsies were removed from the ethanol solution 1 h prior to scanning, placed on the scanner bed and scanned in air. All scans were performed at an isotropic image pixel size of 17.3 mm, 0.5 mm aluminium filter, 0.4 degrees rotation step and a frame average setting of 4. Cross-section images were reconstructed (N-Recon software, v 1.7.1.0, Bruker) and realigned (Dataviewer software, v 1.5.2.4, Bruker) in order to have the vertical axis of the bone cylinder aligned with the inferior-superior direction in the image stack. 25 A cylindrical volume of interest of diameter 2.7 mm and length 13 mm, which excluded any cortical bone, was then contoured on each bone biopsy for analysis. Images were thresholded and the following morphometric parameters calculated (CTAn software (v.1.16.4.1, Bruker) 24, 25 : trabecular bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp), and structure model index (SMI). 
Histology
Following micro-CT analysis, bone core biopsies were decalcified in Osteosoft 1 (Merck, Darmstadt, Germany) and embedded in paraffin for sectioning. Sections 5 mm thick were stained for TRAP activity and counterstained with haematoxylin for visualization of bone histology. Images were acquired using a Nanzoomer (Hamamatsu Photonics, Hamamatsu City, Japan).
Real-Time Reverse Transcription PCR
Bone biopsies collected fresh from surgery were rinsed in cold Phosphate Buffered Saline (PBS) to remove loosely adherent tissue, snap frozen on dry ice, crushed, and processed for RNA extraction using the TRIzol method, as per the manufacturer's instructions. Real-time RT-PCR was performed essentially as previously described. 26 Briefly, 100 ng of RNA was reverse transcribed into cDNA using the iScript cDNA Synthesis Kit (Biorad, CA), as described in the manufacturer's instructions. RT-PCR was performed using a CFX Connect Real Time PCR System (Biorad) and SYBR Green Fluor qPCR Mastermix (Qiagen, Limburg, The Netherlands) in a reaction mixture containing 25 ng cDNA template and 250 nM forward and reverse oligonucleotide primers (Geneworks, Adelaide, Australia). Primers (Table 1) were designed in-house from published gene sequences, such that at least one per pair flanked an intron-exon boundary and were therefore mRNA-specific. The cycling conditions were: 95˚C for 10 min, then 40 cycles of 95˚C for 10 s, 60˚C for 30 s and 72˚C for 30 s. Genes examined were related to two possible modes of bone loss, osteoclastic bone resorption (RANKL:OPG, CTSK, TRAP, CA2), and osteocytic osteolysis (CTSK, TRAP, CA2, MMP13, SOST), and to bone homeostasis (HIF1A, MMP13, COL1A1). 17, 27 Relative gene expression was calculated normalised to 18S rRNA expression.
Statistical Analysis
Descriptive statistics and frequency tables are presented in Table 2 . Each subject had site-matched bone samples taken from their injured and uninjured leg, resulting in correlation within patient for each outcome. To account for this clustering, linear mixed-effects regression models were used throughout, while a two-tailed paired Student's t-test was used to directly compare micro-CT structural parameters. Using the five morphometric parameters: BV/ TV, Tb.Th, Tb.N, Tb.Sp, and SMI in separate linear mixed-effects models, the difference in each parameter between injured and uninjured sides was investigated, significance being assumed to be for p 0.05. Possible associations between these five morphometric parameters and various demographic and genetic expression factors were then investigated. The demographic factors included time between injury and surgery, age, sex, mechanism of injury, smoking status, pre-operative haemoglobin, diabetes, and body mass index (BMI). The genetic expression 
RESULTS
Study Group and Fracture Classification
Throughout the study period, 32 of 95 patients treated in our institution for a unilateral TPF agreed to participate. Of the 32 patients, three were excluded because the biopsies taken from the fracture site were <10 mm in length due to fragmentation on delivery from the biopsy needle or fracture comminution and therefore deemed too small for micro-CT analysis. Therefore, the final study group included 29 patients. Patient demographics are summarized in Table 2 . There were 16 male and 13 females with a mean age at time of surgery of 47.9 years (range 20-80 years). Using the AO classification system there were five 41B2, 13 41B3, four 41C1, four 41C2 and 3 41C3 fractures. Using the Schatzker system there were 12 type II, 9 type IV, and 8 type VI fractures in the cohort. The mean time to surgery was 5.6 days (range 1-17 days).
Bone Microarchitecture
Across the entire cohort, statistically significant differences in morphometric parameters between the injured and the uninjured tibia were found ( Fig. 2A) : compared to the contralateral side, in the injured knee the BV/TV was diminished (À13.5 AE 6.0%, p ¼ 0.012), as well as Tb.N (À10.5 AE 5.9%, p ¼ 0.041) and Tb.Th (À4.6 AE 2.5%, p ¼ 0.039) (Fig. 2, Table 3 ). Sub-group analysis comparing patients treated between 1 and 4 days (n ¼ 15) with those treated between 5 and 17 days (n ¼ 11) following fracture, revealed that significant bone loss was most apparent in the latter group, while bone loss within the first 4 days was not statistically significant (Fig. 2B-D,  Table 3 ). A negative correlation was found in the injured side between both Tb.Th (r ¼ À0.54, p ¼ 0.005; Fig. 3A ) and BV/TV (r ¼ À0.39, p < 0.05; Fig. 3B ) with a delay to surgery. None of the other structural parameters examined correlated with delay to surgery (Table 4 ). In the contralateral knee, none of the morphometric parameters correlated with time since injury.
Gene Expression
Of the 29 patient samples, 14 were also processed for gene expression analysis of a number of genes (listed Table 1 ) associated with bone loss and remodeling, comparing the injured and contralateral limb sides. No differences were found in mean gene expression levels between injured and control samples for any of the genes analyzed. Furthermore, no significant timedependent gene expression patterns were evident, perhaps relating to the relatively small number of samples analyzed.
Normalized gene expression levels were also compared with bone structural parameters to identify potential pathways of bone loss. Analysis revealed negative correlations between %BV/TV and the expression of bone resorption markers TRAP (r ¼ À0.56, p ¼ 0.0047) and the RANKL:OPG mRNA ratio (r ¼ À0.67, p ¼ 0.0007), consistent with increased osteoclastic activity being responsible for the loss of bone volume ( Table 5 ). The influence of osteoclastic activity was most evident on trabecular thickness in these samples, since strong associations were evident between Tb.Th and cathepsin K (CTSK) (r ¼ À0.57, p ¼ 0.0025), TRAP (r ¼ À0.79, p < 0.0001) and the RANKL:OPG mRNA ratio (r ¼ À0.69, p ¼ 0.002) (Table 5, Fig. 4 . Interestingly, these structure-gene expression relationships did not exist in contralateral samples, suggesting that fracture strongly induces bone remodeling in human cancellous bone. There was, however, a positive relationship between HIF1A mRNA expression and Tb.Th that was present in both the injured (r ¼ 0.59, p ¼ 0.002) and uninjured (r ¼ 0.55, p ¼ 0.036) sides. CA2 mRNA expression was found to correlate with Tb.Th (r ¼ 0.56, p ¼ 0.01) in the control but not the injured samples. No correlation was found between the gene expression of genes associated with bone homeostasis and osteocytic removal of bone, SOST and MMP13, with alteration in the microarchitecture of the injured leg (Table 5) , further implicating osteoclasts as the major mediator of early bone loss in cancellous fractures.
No associations were found between the type of fracture, patient age, BMI, cause of injury, diabetes, or smoking status with alterations in either gene expression or micro-CT data.
Histological Analysis
Staining decalcified sections for the osteoclast histological marker TRAP revealed qualitatively more osteoclasts present in biopsies taken from the injured side compared to the contralateral side (Fig. 5) .
DISCUSSION
In this study, a statistically significant, early, timedependent bone loss was found to occur in a periarticular fracture site in cases of TPF. Our findings are consistent with bone in the injured limb adopting a state of increasing catabolism with time following injury. We demonstrated trabecular bone loss in the fractured compared to the uninjured limb, as evidenced through diminished bone volume fraction (BV/ TV), trabecular number (Tb.N) and thickness (Tb.Th). While bone loss was not discernible within the first 4 days following injury in the cohort studied, subgroup analysis of patients treated between 5 and 17 days following injury did reveal significant changes in these parameters. Of note, these measurements were of cylindrical biopsies, and so likely underestimate bone loss due to resorption of cancellous fragments in the injured side. Cancellous bone fracture repair, unlike that of cortical bone fractures, appears to occur by a membranous bone formation process, without either a cartilaginous intermediate or formation of callus. 28 Importantly, this repair process is quite localized and spatially restricted. 28 Excessive bone loss prior to fixation could therefore restrict the ability of trabeculae to "knit together," suggesting that the bone loss observed in this study may negatively affect the healing process following fixation. As also discussed by Sanberg and Aspenberg, 28 evidence suggests that the bone formation phase of cancellous fracture healing is followed by a bone remodeling/ resorption phase and inhibition of osteoclastic activity can promote localized bone mass. Based on this, it may be pertinent to determine what effect elevated bone resorption prior to fixation, such as that indicated in the injured side within the current patient cohort, may have on treatment outcomes. While the sequelae of cancellous bone fracture and mechanisms of repair are not fully understood, particularly in humans, here we found that BV/TV and Tb. Th were inversely correlated to the RANKL:OPG mRNA ratio in the injured tibiae of TPF patients. This is similar to a previous study from our group, which showed that the RANKL:OPG mRNA ratio correlated negatively with BV/TV calculated using two-dimensional histomorphometry, and also correlated positively with the bone remodeling indices eroded surface/bone surface (%ES/BS) and osteoid surface/ bone surface (%OS/BS), in femoral core biopsies taken from patients suffering a fractured neck of femur. 29 An elevated RANKL:OPG mRNA ratio in iliac biopsies was previously shown to be associated with an increased risk of hip fracture in humans. 30 In the current study, the relationships between bone structure and the RANKL:OPG mRNA ratio were not significant in the uninjured side, suggesting that this molecular index is only useful in injured (in this case fractured) bone, which perhaps helps explain the general disparity between localized gene expression of RANKL and corresponding circulating levels of RANKL protein. 16 Also consistent with osteoclastic bone resorption of the injured side, negative correlations were observed between BV/TV and Tb.Th and expression of TRAP mRNA, the gene encoding the major histological marker of osteoclasts. Tb.Th also correlated strongly and inversely with CTSK mRNA expression, the gene encoding the major osteoclastic protease, cathepsin K. The expression of the osteocyte product SOST, shown to have key roles in osteocyte control of bone mass and MMP13, a collagenase expressed in bone by cells of the osteoblast/osteocyte lineage, 31 did not relate to bone structure, supporting a chiefly osteoclast-driven pathway of bone loss. Interestingly, CA2, a gene we have described as important for osteocyte-derived bone loss (osteocytic osteolysis) in addition to its known function in osteoclastic bone resorption, 17 was found to correlate with Tb.Th in the control but not the injured samples obtained. Furthermore, TRAP expression has also been associated with osteocytic osteolysis [17] [18] [19] ; it remains to be seen if osteocytic osteolysis plays a role in the bone loss observed here. The expression of COL1A1 mRNA, encoding type I collagen, the major bone organic matrix protein, was unchanged, consistent with bone formation being unaffected in each limb at sites distal to the fracture itself and the highly localized nature of cancellous bone fracture repair. HIF1A, a gene associated with either osteoclast activation or inhibition, 32 correlated with Tb.Th in both injured and uninjured sides, underscoring the importance of this transcription factor in bone homeostasis.
Our findings are consistent with the recognized association between delay in fracture fixation and poor outcome. 4, 5 The time dependent bone loss observed in this study was independent of previously identified risk factors for bone loss and delayed wound healing, including smoking [33] [34] [35] and type 2 diabetes mellitus. 36, 37 This bone loss implies that delay in fixation could compromise the integrity of cancellous fracture fragments, how effectively they are handled intraoperatively, and potentially the quality of the fixation achievable. Dailey et al. 4 found that in addition to delay to surgery, increased age also contributed to poorer outcomes in terms of fracture fixation; our findings suggest that an effect of age could be secondary to age-related bone loss.
If an increased RANKL:OPG ratio does, as our data suggests, drive cancellous bone loss in the injured limb, then therapeutic targeting of this pathway could lead to improved clinical outcomes. The anti-RANKL treatment Denosumab was reported to have no adverse effect on delay of fracture healing in subjects being treated for osteoporosis. 38 Consistent with this, screw fixation in the rat proximal tibia was improved if the anti-RANKL agent Fc-OPG was administered. 39 If the bone loss identified in the current study relates to patient outcomes in follow-up studies, a randomized placebo controlled clinical trial to test the utility of adjunct anti-resorptive therapy for the specific case of TPF may be warranted.
The study has several limitations. First, the study sample size of 29 patients was only 30.5% of 
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all TPF patients treated in our institution during the study period and therefore our cohort may not be fully representative. Despite this, the cohort included a wide range of patient ages, BMI and cause of injury, and had equal gender distribution that we feel is representative of a typical cohort of patients with TPF. Second, there were a number of exclusions from the cohort due to difficulty in assessment of bone microarchitecture, and gene expression analysis was conducted on 14 (48%) cases. In regard to assessment using micro-CT, three of the 32 (9%) samples were of insufficient quality to be assessed; however it is not known if this was related to the actual injury or the biopsy and harvesting procedure for these patients. Third, only large fracture fragments were biopsied; smaller fragments were not considered for biopsies because their anatomy (micro-architecture) was potentially influenced by the injury, fracture manipulation before the biopsies were taken and difficulty in orientating the samples for micro-CT. Fourth, the contralateral leg was used as the control and the control sample could have been affected by the patient decreased mobility due to injury, and the fact that injury could influence bone metabolism systemically. However, a previous study in iliac crest biopsies suggested that prolonged bed rest results in trabecular bone loss at a rate of $1.5% per month, 40 much lower than the degree of apparent trabecular bone loss recorded in the injured limbs of our cohort (À13.5% in 5 days, on average). This difference could be due to the iliac crest being a typical non-load bearing site during normal daily activity, as opposed to the proximal tibia examined here. 41 By using the contralateral limb as a control, variations in bone loss between individuals as a result of bed rest that would be typical in patients with TPF awaiting surgical intervention are better accounted for. Fifth, despite all efforts made to take samples from the exact corresponding site of the injured and uninjured legs, it is possible that regional variability in proximal tibial microstructure may have affected the results. We believe this influence was minimized by taking biopsies more than 6 mm distal from the articular surface, which represents a relatively homogenous region of the proximal tibia. 23 Finally, despite the current state of knowledge indicating that cancellous bone fracture healing occurs by an intramembranous formation process, 28 it is possible that the catabolic gene expression pattern observed in the injured side is reflective of the initiation of a fracture repair response, however this will require further study. Despite these limitations, this to our knowledge is the first study with bilateral data showing significant correlations between altered gene expression and bone structure in patients having sustained cancellous bone injury, offering useful insight into the biology of human cancellous bone fracture healing.
CONCLUSIONS
Our study has shown for the first time that there is a very early, time-dependent loss of bone in patients having sustained TPF that does not exist in the uninjured limb. This loss is associated with alteration in genes previously associated with osteoclastic bone resorption, and these relationships were only evident in the injured limb. We suggest that such cancellous bone loss could impair the ability to achieve anatomic reduction and optimal fixation in cases operated more than 4 days after injury, however further studies are needed to determine if this is the case.
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